Woman and Man
- | Country :
- Poland
- Denmark
- Norway
- The 11 others...
- | organs : -
- | Specialty : -
Extract
The primary objective is to: - demonstrate the efficacy of SR123781A in the prevention of venous thromboembolism (VTE) by the demonstration of a dose-response in patients undergoing total hip replacement surgery. The secondary objectives are to: - evaluate the safety of SR123781A in the prevention of VTE after elective total hip replacement surgery; and - to assess the SR123781A pharmacokinetic profile in patients undergoing elective total hip replacement surgery.
Inclusion criteria
- Venous Thromboembolism